AR074046A1 - Envase para la administracion iontoforetica de un farmaco - Google Patents

Envase para la administracion iontoforetica de un farmaco

Info

Publication number
AR074046A1
AR074046A1 ARP090103414A ARP090103414A AR074046A1 AR 074046 A1 AR074046 A1 AR 074046A1 AR P090103414 A ARP090103414 A AR P090103414A AR P090103414 A ARP090103414 A AR P090103414A AR 074046 A1 AR074046 A1 AR 074046A1
Authority
AR
Argentina
Prior art keywords
packaging
component
houses
iontophoretic
pharmaco
Prior art date
Application number
ARP090103414A
Other languages
English (en)
Original Assignee
Travanti Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Travanti Pharma Inc filed Critical Travanti Pharma Inc
Publication of AR074046A1 publication Critical patent/AR074046A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Electrotherapy Devices (AREA)
  • Packages (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente se refiere en general a sistemas de administracion iontoforética de un fármaco para la administracion transdérmica de agentes terapéuticos y, más particularmente, al envasado de tales sistemas para una vida util prolongada y fácil ensamblado para el uso. El envase del sistema incluye un componente de parche iontoforético que se lleva sobre la piel, que aloja una fuente de energía eléctrica, elementos electronicos, electrodos y un componente de envase del fármaco que aloja un agente terapéutico que está contenido como un componente sellado separado. El sistema envasado provee además una mayor facilidad de ensamblado en el momento de uso.
ARP090103414A 2008-09-05 2009-09-04 Envase para la administracion iontoforetica de un farmaco AR074046A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9444208P 2008-09-05 2008-09-05

Publications (1)

Publication Number Publication Date
AR074046A1 true AR074046A1 (es) 2010-12-22

Family

ID=41797377

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103414A AR074046A1 (es) 2008-09-05 2009-09-04 Envase para la administracion iontoforetica de un farmaco

Country Status (15)

Country Link
US (3) US9492650B2 (es)
EP (1) EP2331199A4 (es)
JP (1) JP5514823B2 (es)
KR (1) KR101267728B1 (es)
CN (1) CN102202728A (es)
AR (1) AR074046A1 (es)
AU (1) AU2009288680B2 (es)
BR (1) BRPI0920522A2 (es)
CA (1) CA2735789C (es)
EA (1) EA022414B1 (es)
IL (1) IL211505A (es)
MX (1) MX2011002407A (es)
NZ (2) NZ591334A (es)
WO (1) WO2010027468A1 (es)
ZA (1) ZA201101327B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120259269A1 (en) 2011-04-08 2012-10-11 Tyco Healthcare Group Lp Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
DE102011109338B3 (de) * 2011-08-03 2013-01-31 Dietrich Reichwein Vorrichtung zur Speicherung elektromagnetischer Energie
US20140058339A1 (en) * 2012-08-22 2014-02-27 Mark L. Baum Method and apparatus for self-dosing and self-administering pharmaceutical compositions
EP2886153A1 (de) * 2013-12-20 2015-06-24 LTS LOHMANN Therapie-Systeme AG System für die transdermale Abgabe von Wirkstoff
AU2017387141A1 (en) 2016-12-29 2019-07-18 Pure Ratios Holdings, Inc. Modular transdermal delivery system and associated methods of manufacture and use
US10953096B2 (en) 2017-04-28 2021-03-23 Nitto Denko Corporation Transdermal absorption preparation precursor
WO2019241711A1 (en) 2018-06-14 2019-12-19 Sabiev Anton Wireless iontophoresis patch and controller

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695464A (en) 1984-10-09 1987-09-22 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
DE3903794A1 (de) * 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
HUT65957A (en) * 1992-03-17 1994-08-29 Becton Dickinson Co User operated iontophoretical device and method for manufacturing it
JP2542792B2 (ja) * 1992-11-05 1996-10-09 ベクトン・ディッキンソン・アンド・カンパニー ユ―ザ作動型のイオン導入式装置
FR2709670B1 (fr) * 1993-09-10 1995-10-20 Asulab Sa Dispositif en trois modules pour l'administration transdermique de médicaments par électrophorèse ou iontophorèse.
JPH09511671A (ja) * 1994-08-22 1997-11-25 イオメド インコーポレイテッド 水和水段を組み込んだイオントフォレティック（ｉｏｎｔｏｐｈｏｒｅｔｉｃ）デリバリー装置
US5738647A (en) * 1996-09-27 1998-04-14 Becton Dickinson And Company User activated iontophoretic device and method for activating same
JP4154016B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置およびその組み立て方法
JPH11239621A (ja) * 1998-02-25 1999-09-07 Hisamitsu Pharmaceut Co Inc イオントフォレーシス装置
JP2002542498A (ja) * 1999-04-22 2002-12-10 シグナス， インコーポレイテッド 干渉種を除去するための方法およびデバイス
US6953446B2 (en) * 2001-09-21 2005-10-11 Iomed, Inc. Method and device for the iontophoretic delivery of a drug
NZ534149A (en) * 2001-12-19 2005-12-23 Alza Corp Reservoir housing having a conductive region integrally formed therein
CA2453013C (en) 2002-12-13 2011-02-15 Gary W. Cleary Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US6745071B1 (en) * 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
GB0320312D0 (en) 2003-08-29 2003-10-01 Novartis Ag Purification process
WO2005063331A1 (ja) * 2003-12-26 2005-07-14 Hisamitsu Pharmaceutical Co., Inc. 用時活性化型イオントフォレーシスデバイス
US20050228336A1 (en) * 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability

Also Published As

Publication number Publication date
IL211505A0 (en) 2011-05-31
ZA201101327B (en) 2012-05-30
US20170120047A1 (en) 2017-05-04
NZ604902A (en) 2014-06-27
WO2010027468A1 (en) 2010-03-11
KR20110063515A (ko) 2011-06-10
NZ591334A (en) 2013-03-28
BRPI0920522A2 (pt) 2019-09-24
MX2011002407A (es) 2011-07-28
CN102202728A (zh) 2011-09-28
CA2735789A1 (en) 2010-03-11
US20120022431A1 (en) 2012-01-26
AU2009288680A1 (en) 2010-03-11
US9492650B2 (en) 2016-11-15
CA2735789C (en) 2016-10-11
AU2009288680B2 (en) 2013-07-04
US20130018298A1 (en) 2013-01-17
EP2331199A4 (en) 2011-11-30
JP5514823B2 (ja) 2014-06-04
EP2331199A1 (en) 2011-06-15
JP2012501723A (ja) 2012-01-26
EA201100428A1 (ru) 2011-10-31
EA022414B1 (ru) 2015-12-30
IL211505A (en) 2014-09-30
KR101267728B1 (ko) 2013-05-24

Similar Documents

Publication Publication Date Title
AR074046A1 (es) Envase para la administracion iontoforetica de un farmaco
ES2552308T3 (es) Sistema de estimulación transcutánea
CO6501129A2 (es) Composicion antitranspirante/desorodante anhidra líquida
TR201902125T4 (tr) Si̇stemi̇k olarak etki̇ eden akti̇f ajanlari i̇çeren parazi̇ti̇si̇dal oral veteri̇nerli̇ğe ai̇t bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari
CR20120345A (es) Derivados de 3-hidroxi-5-arilisotiazol novedosos
GT201400285A (es) Formulacion de anticuerpos
CL2015001695A1 (es) Una composicion de dos componentes para entregar zinc a un cuerpo comprendiendo (i) un primer componente de un complejo de halogenuro de zinc y (aminoacido o trialquilglicina) y (ii) un segundo componente de cisteina, en donde el primer y segundo componente se mantienen separados uno del otro hasta que se dispensan y se combinan para aplicarse al cuerpo, util para el cuidado oral y personal.
BR112016000194A8 (pt) forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
CO7111300A2 (es) Formulación de anticuerpos
MY163809A (en) Transdermal drug delivery system containing donepezil
WO2010068281A3 (en) Contact lens drug delivery device
MX2010004169A (es) Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
CL2016000950A1 (es) Composición farmacéutica acuosa que comprende insulina glulisina y metionina; kit farmacéutico; uso en el tratamiento de la diabetes tipo 1 ó 2.
CO6410278A2 (es) Disoluciones pediátricas que continen un beta-bloqueante
IN2012DN01225A (es)
IN2014DN09817A (es)
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
AR084914A1 (es) Dispositivo medico que contiene una composicion en torta que comprende aripiprazol como ingrediente activo, y una composicion en torta que comprende aripiprazol como ingrediente activo, metodo
CL2013002700A1 (es) Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros
AR090930A1 (es) Composiciones oftalmicas con proteccion mejorada contra la desecacion y retencion
AR092840A1 (es) Elaboracion de degarelix
IL273329A (en) Modulation of hepatic-hepatic epidermal growth factor activity to heal the eardrum membrane
CL2016001130A1 (es) Composiciones sólidas de triglicéridos y usos de estas
TR201910287T4 (tr) Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli.
BR112012014107B8 (pt) sistema terapêutico transdérmico (tts) e processo de produção de tts

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee